Dr. Julie R. Gralow

powered by
COS Expertise®
University of Washington
School of Medicine
Medical Oncology
Associate ProfessorAppointed: 2002
Professional Headshot of Julie R. Gralow

Mailing Address

Seattle Cancer Care Alliance
UW Box 358081; MS G4-830
825 Eastlake Avenue E.
Seattle, Washington 98109
United States

Contact Information

Phone: (206) 288-7722
Fax: (206) 288-2054
pink@u.washington.edu

Qualifications

M.D., University Southern California, 1988.
B.S., Stanford University, 1981.

Expertise and Research Interests

Julie Gralow majored in biologic sciences at Stanford University before attending medical school at the University of Southern California. She did a residency in internal medicine at Harvard Medical School's Brigham and Women's Hospital, followed by a medical oncology fellowship at the University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center, two institutions at which she currently holds joint faculty appointments.

Specializing in breast cancer, Dr. Gralow is the co-Chair of the Southwest Oncology Group's Breast Cancer Committee. She is the principle investigator on several clinical trials related to breast cancer treatment.

Dr. Gralow is committed to improving quality of life for breast cancer patients through education, exercise and diet, and to promoting breast cancer awareness in the community. Dr. Gralow is the Medical Director and Team Physician for 'Team Survivor Northwest,' a group of female cancer survivors dedicated to improving their health through fitness and exercise.

She is board-certified in in medical oncology, and is a member of the American Association for Cancer Research, American Society of Clinical Oncology, National Alliance of Breast Cancer Organizations, Southwest Oncology Group, and the American Society of Breast Disease.

Keywords

COS Keywords:

Breast Cancer, Cancer or Carcinogenesis, Health and Medicine, Oncogenes, Oncology, Tumors.

Additional Terms:

Breast Cancer, Cancer, Oncogenes, Oncology, Tumor Biology.

Publications

  • Garrison JA, McCune JS, Livingston RB, Linden HM, Gralow JR, Ellis GK, West HL, Myalgias and arthralgias associated with paclitaxel, Oncology (williston Park, N.y.), 17(2), 271-7; discussion 28, February 2003 Abstract
  • Gralow JR, Bisphosphonates as adjuvant treatment for breast cancer, Bmj (clinical Research Ed.), 325(7372), 1051-2, November 2002 Abstract
  • Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Schubert EK, Charlop AW, Tseng J, Rinn KJ, Livingston RB, [Tc-99m]-sestamibi uptake and washout in locally advanced breast cancer are correlated with tumor blood flow, Nuclear Medicine and Biology, 29(7), 719-27, October 2002 Abstract
  • Ellis GK, Livingston RB, Gralow JR, Green SJ, Thompson T, Dose-dense anthracycline-based chemotherapy for node-positive breast cancer, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(17), 3637-43, September 2002 Abstract
  • Stafford SE, Gralow JR, Schubert EK, Rinn KJ, Dunnwald LK, Livingston RB, Mankoff DA, Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy, Academic Radiology, 9(8), 913-21, Aug 2002 Abstract
  • Winer EP, Hudis C, Burstein HJ, Chlebowski RT, Ingle JN, Edge SB, Mamounas EP, Gralow J, Goldstein LJ, Pritchard KI, Braun S, Cobleigh MA, Langer AS, Perotti J, Powles TJ, Whelan TJ, Browman GP, American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 200, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(15), 3317-27, Aug 2002 Abstract
  • Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Charlop A, Lawton TJ, Schubert EK, Tseng J, Livingston RB, Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy, Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine., 43(4), 500-9, April 2002 Abstract
  • Eubank WB, Mankoff DA, Vesselle HJ, Eary JF, Schubert EK, Dunnwald LK, Lindsley SK, Gralow JR, Austin-Seymour MM, Ellis GK, Livingston RB, Detection of locoregional and distant recurrences in breast cancer patients by using FDG PET, Radiographics : a Review Publication of the Radiological Society of North America, Inc., 22(1), 5-17, 2002 Abstract
  • Gralow JR, The role of bisphosphonates as adjuvant therapy for breast cancer, Current Oncology Reports, 3(6), 506-15, November 2001 Abstract
  • Wilkie DJ, Huang HY, Berry DL, Schwartz A, Lin YC, Ko NY, Chen A, Gralow J, Lindsley SK, Fitzgibbon D, Cancer symptom control: feasibility of a tailored, interactive computerized program for patients, Family and Community Health, 24(3), 48-62, October 2001 Abstract
  • Gralow JR, Livingston RB, University of Washington high-dose cyclophosphamide, mitoxantrone, and etoposide experience in metastatic breast cancer: unexpected cardiac toxicity, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(18), 3903-4, September 2001 Abstract
  • Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL, Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma, Cancer, 92(4), 720-9, August 2001 Abstract
  • Eubank WB, Mankoff DA, Takasugi J, Vesselle H, Eary JF, Shanley TJ, Gralow JR, Charlop A, Ellis GK, Lindsley KL, Austin-Seymour MM, Funkhouser CP, Livingston RB, 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(15), 3516-23, August 2001 Abstract
  • Mankoff DA, Peterson LM, Tewson TJ, Link JM, Gralow JR, Graham MM, Krohn KA, [18F]fluoroestradiol radiation dosimetry in human PET studies, Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine., 42(4), 679-84, April 2001 Abstract
  • Bellon JR, Lindsley KL, Ellis GK, Gralow JR, Livingston RB, Austin Seymour MM, Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer, International Journal of Radiation Oncology, Biology, Physics, 48(2), 393-7, September 2000 Abstract
  • Bernhard H, Huseby ES, Hand SL, Lohmann M, Batten WY, Disis ML, Gralow JR, Meyer zum Buschenfelde KH, Ohlen C, Cheever MA, Dendritic cells lose ability to present protein antigen after stimulating antigen-specific T cell responses, despite upregulation of MHC class II expression, Immunobiology, 201(5), 568-82, April 2000 Abstract
  • Bowen D, McTiernan A, Burke W, Powers D, Pruski J, Durfy S, Gralow J, Malone K, Participation in breast cancer risk counseling among women with a family history, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 8(7), 581-5, July 1999 Abstract
  • Mankoff DA, Dunnwald LK, Gralow JR, Ellis GK, Drucker MJ, Livingston RB, Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography, Cancer, 85(11), 2410-23, June 1999 Abstract
  • Ellis GK, Gralow JR, Pierce HI, Williams MA, Livingston RB, Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast cancer: high complete response rate in a phase I-II study of doxorubicin-treated patients., Journal of Clinical Oncology, 17(5), 1407-12, May 1999 Abstract
  • Hathaway PB, Mankoff DA, Maravilla KR, Austin-Seymour MM, Ellis GK, Gralow JR, Cortese AA, Hayes CE, Moe RE, Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience, Radiology, 210(3), 807-14, March 1999 Abstract
  • McTiernan A, Ulrich C, Kumai C, Bean D, Schwartz R, Mahloch J, Hastings R, Gralow J, Potter JD, Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: results of a pilot study, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 7(6), 477-81, June 1998 Abstract
  • Disis ML, Pupa SM, Gralow JR, Dittadi R, Menard S, Cheever MA, High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 15(11), 3363-7, November 1997 Abstract
  • Clark JI, Alpaugh RK, von Mehren M, Schultz J, Gralow JR, Cheever MA, Ring DB, Weiner LM, Induction of multiple anti-c-erbB-2 specificities accompanies a classical idiotypic cascade following 2B1 bispecific monoclonal antibody treatment, Cancer Immunology, Immunotherapy : Cii, 44(5), 265-72, July 1997 Abstract
  • Livingston RB, Ellis GK, Gralow JR, Williams MA, White R, McGuirt C, Adamkiewicz BB, Long CA, Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer., Journal of Clinical Oncology, 15(4), 1395-400, 1997 Abstract
  • Disis ML, Bernhard H, Shiota FM, Hand SL, Gralow JR, Huseby ES, Gillis S, Cheever MA, Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines, Blood, 88(1), 202-10, July 1996 Abstract
  • Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W, Immunity to oncogenic proteins, Immunological Reviews, 145, 33-59, June 1995 Abstract
  • Bernhard H, Disis ML, Heimfeld S, Hand S, Gralow JR, Cheever MA, Generation of immunostimulatory dendritic cells from human CD34+ hematopoietic progenitor cells of the bone marrow and peripheral blood, Cancer Research, 55(5), 1099-104, March 1995 Abstract
  • Disis ML, Bernhard H, Gralow JR, Hand SL, Emery SR, Calenoff E, Cheever MA, Immunity to the HER-2/neu oncogenic protein, Ciba Foundation Symposium, 187, 198-207; discussion, 1994 Abstract
  • Miller RA, Lowder JN, Gralow J, Meeker T, Levy R, In vitro tests that predict tumor-associated idiotype levels in the serum of patients with B cell lymphomas and leukemias, Blood, 69(4), 1249-54, April 1987 Abstract
  • Lowder JN, Meeker TC, Campbell M, Garcia CF, Gralow J, Miller RA, Warnke R, Levy R, Studies on B lymphoid tumors treated with monoclonal anti-idiotype antibodies: correlation with clinical responses, Blood, 69(1), 199-210, January 1987 Abstract
  • Dubeau L, Chandler LA, Gralow JR, Nichols PW, Jones PA, Southern blot analysis of DNA extracted from formalin-fixed pathology specimens, Cancer Research, 46(6), 2964-9, June 1986 Abstract
  • Thompson JM, Gralow JR, Levy R, Miller RA, The optimal application of forward and ninety-degree light scatter in flow cytometry for the gating of mononuclear cells, Cytometry : the Journal of the Society for Analytical Cytology, 6(5), 401-6, September 1985 Abstract
  • Miller RA, Gralow J, The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA), Journal of Immunology (baltimore, Md. : 1950), 133(6), 3408-14, December 1984 Abstract
  • Sklar J, Cleary ML, Thielemans K, Gralow J, Warnke R, Levy R, Biclonal B-cell lymphoma, The New England Journal of Medicine, 311(1), 20-7, July 1984 Abstract
  • Thielemans K, Maloney DG, Meeker T, Fujimoto J, Doss C, Warnke RA, Bindl J, Gralow J, Miller RA, Levy R, Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas, Journal of Immunology (baltimore, Md. : 1950), 133(1), 495-501, July 1984 Abstract

Profile Details

Last Updated: 7/20/2003

COS Expertise ID #135361
Reference this profile directly: http://myprofile.cos.com/GRALOW